baber/WOPTO huggingface dataset:
Patent AU-595715-B2 (AU)
Title: A computer-controlled switching system, in particular a so-called key telephone switching system
Inventor: BOETTGER DETLEV
IPC: H04M9/00
Filed: 1988-06-15
Granted: 1990-04-05
Abstract: Controlled by the central control processing unit (ZSt), which is responsible for switching operations, not only audible but also independent visual communication is provided in an exchange (VE). This can be carried out in parallel with a call which has been set up or when the terminals concerned are idle. A specific information block, selected from several possible information blocks which are stored in listed form in a memory (T), is displayed selectively at the required terminal without affecting switching system operations. The information which corresponds or is to be allocated to the selected information block is presented, for example, on the display (DL). In the case of special user configurations (e.g. Manager/Secretary systems), the permanent address allocation is predefined in the customer data store (KD) for this visual communication, i.e. wherein the actual speech path (switching device, PCM highway) is not occupied. The individual texts which are to be presented on the display (DL) via the control channel (c/d) may be selected from all the stored texts by means of, for example, a key permanently assigned to each text or through a corresponding procedure. <IMAGE>
Patent AU-655281-B2 (AU)
Title: Improvements in and relating to particle detection and analysis
Inventor: WALKER MALCOLM JAMES
IPC: G01N29/04
Filed: 1992-05-20
Granted: 1994-12-15
Abstract: PCT No. PCT/GB92/00917 Sec. 371 Date Jan. 7, 1994 Sec. 102(e) Date Jan. 7, 1994 PCT Filed May 20, 1992 PCT Pub. No. WO92/21021 PCT Pub. Date Nov. 26, 1992.The invention provides a method of, and apparatus for detecting and analyzing moving particles using an impact responsive transducer which generates a detection signal having an amplitude related to force of particle impact. The transducer output signal is monitored and when it exceeds a given threshold, any local maximum values are noted. Those values are compared to determine which has the overall maximum amplitude. A final signal is then generated in order to provide a representation of the maximum value, and hence the momentum and time occurrence of a particle impact.
Patent AU-602594-B2 (AU)
Title: Certain 1,2-benzisoxazole and 1,2-benzisothiazole derivatives
Inventor: BOWMAN ROBERT M
IPC: C07D471/04
Filed: 1988-07-07
Granted: 1990-10-18
Abstract: Disclosed are 1,2-benzisoxazole and 1,2-benzisothiazole derivatives represented by formula I    <IMAGE>  (I)  wherein X represents oxygen or sulfur; Z rep;esents carbon (CH) so as to complete the imidazol-1-yl ring radical or Z represents nitrogen (N) so as to complete the 1,2,4-triazol-1-yl ring radical; R1 represents hydrogen, lower alkenyl, lower alkynyl, aryl-lower alkyl or lower alkyl; R2 represents hydrogen, lower alkenyl, lower alkynyl, aryl-lower alkyl or lower alkyl; or R1 and R2 combined represent lower alkylene; or R1 combined with R5 located on the Z-carbon atom of the imidazolyl radical represents C2-C4-alkylene; R3 and R4 independently represent hydrogen, lower alkyl, cycloalkyl, halogen, trifluoromethyl, cyano, nitro, amino, hydroxy, lower alkanoyloxy, carbocyclic aroyloxy, lower alkoxy, or carbocyclic aryl; or R3 and R4, together when located on adjacent carbon atoms, represent lower alkylenedioxy; or R3 and R4, together when located on the carbon atoms to which attached a benzo-fused or C5-C7-cycloalka-fused ring, respectively; R5 located on carbon represents hydrogen, lower alkyl or hydroxy-lower alkyl; R6 located on carbon represents hydrogen or lower alkyl; or when Z represents carbon, R5 located on the Z-carbon atom combined with R6 located on the adjacent carbon atom represents C3-C5-alkylene; and pharmaceutically acceptable salts thereof; which are active in mammals as anticonvulsant agents.
Patent AU-653247-B2 (AU)
Title: Novel alkoxy substituted taxanes and pharmaceutical compositions containing them
Inventor: HOLTON ROBERT A
IPC: C07D305/14
Filed: 1992-09-04
Granted: 1994-09-22
Abstract: A taxane derivative of the formula <CHEM>  wherein     R<5> is phenyl or substituted phenyl,     R<7> is CH<7>O-, or CH<7>CH<6>O-,     Z is -OT<5>,     T<5> is hydrogen, hydroxyl protecting group, or -COT<6>, T<6> is H, C<5>-C1/4  alkyl, C<5>-C1/4  alkenyl, C<5>-C1/4  alkynyl or monocylic aryl,     Ac is acetyl, and E<5> and E<6> are independently selected from hydrogen and functional groups which increase the water solubility of the taxane derivative are useful as antitumor agents.
Patent AU-645715-B2 (AU)
Title: Thrombin and method of producing the same
Inventor: EIBL JOHANN DR
IPC: A61K35/00
Filed: 1992-10-27
Granted: 1994-01-20
Abstract: The invention relates to a thrombin of human or animal origin, which is free of infectious agents and can be prepared by activation of prothrombin which is subjected to a heat treatment to inactivate infectious agents.
Patent AU-571301-B2 (AU)
Title: Refractory fiber ladle preheater sealing rings
Inventor: HOUNSEL MACK A
IPC: B22D41/05
Filed: 1984-12-19
Granted: 1988-04-14
Abstract: Sealing rings are provided for ladle preheaters. The rings may be either fixedly or removably mounted with the ladle preheater frame. The rings seal about the ladle rim adjacent burner and flue openings of the preheater. Refractory fiber insulation is provided for insulating the space between the rim of the ladle and the preheater to prevent hot gas escaping. The refractory fiber is arranged into trapezoidal units which are easily installed and replaced.
Patent AU-619312-B2 (AU)
Title: Gene encoding 25 kda surface protein of zygotes and ookinetes of plasmodium
Inventor: MILLER LOUIS H
IPC: A61K39/015
Filed: 1989-04-20
Granted: 1992-01-23
Abstract: The invention is a gene for expressing antigens for producing a human malaria vaccine. The gene includes a cloned nucleotide sequence or segment for encoding the 25kDa surface protein of zygotes and ookinetes of Plasmodium falciparum.
Patent AU-760251-B2 (AU)
Title: Acid-base polymer blends and their use in membrane processes
Inventor: KERRES JOCHEN
IPC: C08J5/22
Filed: 1999-04-16
Granted: 2003-05-08
Abstract: The present invention relates to polymer blends and polymer blend membranes which consist of a polymeric sulfonic acid and of a polymer which contains primary, secondary or tertiary amino groups, which are prepared via mixing of a salt of the polymeric sulfonic acid with the polymer which contains primary, secondary or tertiary amino groups. The invention further relates to the use of polymer blend membranes in membrane fuel cells, polymer electrolyte membrane fuel cells (PEM fuel cells) or direct methanol fuel cells (DMFC), in membrane electrolysis, in aqueous or non-aqueous electrodialysis, in diffusion dialysis, in the perstractive separation of alkenes from alkene/alkane mixtures (here the membranes are in the SO3Ag form, where the Ag<+> forms a reversible complex with the alkene (->facilitated transport)), in pervaporative separation of water from water/organics mixtures, or in gas separation.
Patent AU-726305-B2 (AU)
Title: Plating turbine engine components
Inventor: KANG DAVID
IPC: C23C18/31
Filed: 1997-10-10
Granted: 2000-11-02
Abstract: A process is provided for plating a coating onto a gas turbine engine component without detrimentally effecting air flow through cooling holes by injecting a maskant into the cooling passage to fill the cooling holes with the maskant, plating the external surface of the component with a coating, then removing the maskant from the component. <IMAGE>
Patent AU-777853-B2 (AU)
Title: Three-dimensional stromal tissue
Inventor: NAUGHTON GAIL K
IPC: A61K47/34
Filed: 2000-04-12
Granted: 2004-11-04
Abstract: The present invention relates to a method for promoting blood vessel formation in tissues and organs. In particular, the method relates to implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues. The three-dimensional stromal tissue of the present invention may be used in a variety of applications including, but not limited to, promoting repair of and regeneration of damaged cardiac muscle, promoting vascularization and healing during cardiac surgery, promoting blood vessel formation at anastomosis sites, and promoting vascularization and repair of damaged skeletal muscle, smooth muscle or connective tissue.
Patent AU-658531-B2 (AU)
Title: Method and apparatus for producing oriented plastic strap
Inventor: ERDEN DONALD L VAN
IPC: B29C55/18
Filed: 1993-09-22
Granted: 1995-04-13
Abstract: An apparatus and method for producing an oriented plastic strap having a predetermined desired thickness for use in strapping packages and the like is passed between a pair of cylinders or rollers placed closely together at a desired nip for reducing the thickness of the sheet. One roller is rotated at a faster lineal rate of speed than the other, and the rollers rotate in opposite directions. This apparatus and method achieves milling and stretching of the material simultaneously substantially at the nip. <IMAGE>
Patent AU-770403-B2 (AU)
Title: Trans free hard structural fat for margarine blend and spread
Inventor: SAHASRANAMAM U R
IPC: C11B1/10
Filed: 2001-05-25
Granted: 2004-02-19
Abstract: A Trans free hard structural fat suitable for the manufacture of low SAFA(Saturated Fatty Acid) poly/mono unsaturated margarine and spreads and fat blends for margarine/spreads. The structural fat is made from selectively fractionated non-hydrogenated high melting palm oil fraction which is interesterified with dry fractionated non hydrogenated palm kernel fraction with high yield ratios that can be economically and commercially used as structural fat for the aforesaid manufacture.
Patent AU-630143-B2 (AU)
Title: Modulation of adenylate cyclase response
Inventor: WIEGAND KARL E
IPC: A61K31/00
Filed: 1989-12-22
Granted: 1992-10-22
Abstract: Silicic acid modulates (i.e. enhances or inhibits) adenylate cycloase activity. This effect appears to be a general one, inasmuch as the modulation has occurred in all tissues studied. The results suggest that silicic acid can be used in human and veterinary medicine to modulate hormone or neurotransmitter response. The results also indicate that silicic acid can be used to prevent, treat, or delay the onset of calcium-related bone disease, or to improve bone strength in an vertebrate having a bone strength less than desired.
Patent AU-745331-B2 (AU)
Title: Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
Inventor: NOE CHRISTIAN R
IPC: A61P21/00
Filed: 1997-11-11
Granted: 2002-03-21
Abstract: Enantiomerically pure (3R,2'R), (3S,2'R), (3R,2'S) and (3S,2'S) alkyl-cycloalkyl-hydroxycarboxylic acid ester salts of formula (I) are new. R1 = monocyclic, bicyclic or tricyclic 3-9C cycloalkyl (optionally substituted by one or more 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl and/or halo); R2, R3 = 1-6C alkyl, 2-6C alkenyl or 2-6C alkynyl (each optionally halo substituted); Ar = 6-10C aromatic or heteroaromatic containing N, S or O; n = 1-3; A = anion of a pharmaceutically acceptable acid.
Patent AU-691738-B2 (AU)
Title: Process for preparing spirolaxine and spirolaxine methyl ether
Inventor: GUADLIANA MARK ALAN
IPC: C12N1/14
Filed: 1996-03-29
Granted: 1998-05-21
Abstract: PCT No. PCT/IB95/00217 Sec. 371 Date Aug. 13, 1997 Sec. 102(e) Date Aug. 13, 1997 PCT Filed Mar. 30, 1995 PCT Pub. No. WO96/30538 PCT Pub. Date Oct. 3, 1996Processes for preparing spirolaxine and spirolaxine methyl ether, the compounds of formulas (I) and (II) respectively, comprising fermenting fungi selected from the group consisting of Sporotrichum pruinosum FD 29585, ATCC 74327; Sporotrichum pruinosum FD 29454, ATCC 74329; Sporotrichun pruinosum FD 29586, ATCC 74328; and Phanerochaete chrysosporiun LN 3576, ATCC 74326. This invention also relates to a process for preparing spirolaxine comprising fermenting Sporotrichum pruinosum FD 29458, ATCC 74330.
Patent AU-678779-B2 (AU)
Title: Elevator motor placed in the counterweight
Inventor: HAKALA HARRI
IPC: B66B11/04
Filed: 1994-01-11
Granted: 1997-06-12
Abstract: In this invention, an elevator motor (6) provided with an external rotor (17) and a traction sheave (18) is so implemented that it simultaneously constitutes the counterweight (26) of a rope-suspended elevator (1). In this motor/counterweight structure, rotating induction motors can be used. A gear is not necessary because the construction of the invention and the placement of the motor allow the use of a motor with a large diameter and therefore a high torque. As the length of the motor still remains small, the motor/counterweight of the invention can be accommodated in the space normally reserved for a counterweight in an elevator shaft. <IMAGE>
Patent AU-579715-B2 (AU)
Title: Detection of human t-cell leukemia virus type iii
Inventor: SAXINGER CARL W
IPC: G01N33/543
Filed: 1986-02-07
Granted: 1988-12-08
Abstract: This invention discloses a method for detecting antibodies to human T-cell leukemia virus Type III (HTLV-III), the virus associated with Acquired Immune Deficiency Syndrome (AIDS). The method involves use of a peroxidase labeled immunoglobulin which specifically binds to a compatible anti-human immunoglobulin previously bound to NTLV-III antibodies in test sera.
Patent AU-706009-B2 (AU)
Title: Improvements in or relating to plant starch composition
Inventor: COOKE DAVID
IPC: C12N15/54
Filed: 1996-05-03
Granted: 1999-06-03
Abstract: Disclosed is a nucleotide sequence encoding an effective portion of a class A starch branching enzyme (SBE) obtainable from potato plants, or a functional equivalent thereof, together with, inter alia, a corresponding polypeptide, a method of altering the characteristics of a plant, a plant having altered characteristics; and starch, particularly starch obtained from a potato plant, having novel properties.
Patent AU-758017-B2 (AU)
Title: Diagnostic apparatus with radio link
Inventor: UHLEMANN GISELA
IPC: A61B5/00
Filed: 1999-10-20
Granted: 2003-03-13
Abstract: The device has a casing (2) provided with several electrodes (4,8,12) contacting the body for measuring bioelectrical signals, e.g. electrocardiogram signals. The casing contains a voltage supply and an electronic transceiver, e.g. a mobile radio telephone, with the transmission function disconnected during the bioelectrical signal measurement.
Patent AU-688743-B2 (AU)
Title: Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Inventor: ANDERSON DARRELL R
IPC: C12N1/21
Filed: 1993-11-12
Granted: 1998-03-19
Abstract: Disclosed herein is an immunologically active, chimeric anti-CD20 antibody for use as a medicament, which antibody is capable of substantial B-cell depletion when administered to a subject.
Patent AU-619119-B2 (AU)
Title: Apparatus for processing glass
Inventor: HERRINGTON RICHARD A
IPC: C03B35/16
Filed: 1990-05-18
Granted: 1992-01-16
Abstract: An apparatus for processing glass sheets includes a furnace and a bending station traversed by a conveyor for carrying the glass sheets. A plurality of heaters mounted in the furnace each heat associated areas of the glass sheets in accordance with setpoint temperature signals representing desired values of temperatures for heating associated areas of the glass sheets. One or more parameters of the glass sheets, such as thickness and color, are sensed and the setpoint signal values are changed accordingly. The parameter values are also utilized to change the spacing between the upper and lower mold members in the bending station to adjust the bending pressure applied to the glass sheets. Furthermore, the parameters are utilized to change the speed of the conveyor sections in order to vary the time that the glass sheets are in the furnace and thus the amount of heat imparted to the glass sheets.
Patent AU-761357-B2 (AU)
Title: Pharmaceutical compositions with antitumour activity
Inventor: SCANDURRA LAURA
IPC: A61K31/205
Filed: 1999-09-27
Granted: 2003-06-05
Abstract: Acylcarnitines, such as L-acetylcarnitine (I) were found to have marked antitumour activity, which can be further increased by simultaneous administration of somatosstatin.
Patent AU-711618-B2 (AU)
Title: Recombinant bacterial system with environmentally limited viability
Inventor: CURTISS ROY III
IPC: C12N15/09
Filed: 1996-06-07
Granted: 1999-10-21
Abstract: Disclosed is an Environmentally Limited Viability System (ELVS) for microorganisms based on temperature differences between permissive and non-permissive environments. Viability of the microorganisms are limited to the permissive environment by specifically expressing one or more essential genes only in the permissive environment, or expressing one or more lethal genes only in the non-permissive environment. Environmentally Limited Viability Systems are also disclosed involving coordinate expression of a combination of required genes and lethal genes. Microorganisms containing an Environmentally Limited Viability System are useful for release into a permissive environment. Temperature regulated Environmentally Limited Viability Systems are particularly suited for use with recombinant avirulent Salmonella vaccines by limiting their growth to the warmer environment inside the host. Such vaccines can be administered to protect humans or warm-blooded animals against bacterial, viral, mycotic and parasitic pathogens, especially those that colonize on or invade through mucosal surfaces. This antigen delivery system can also be used for expression of gamete-specific antigens to induce immune responses to block fertilization, or to induce immune responses to tumor antigens. In the event that an individual sheds live vaccine into the environment, the presence of the ELVS prevents survival of the vaccine. When environmentally regulated lethal genes are present on an extrachromosomal element and are regulated by chromosomal genes, transfer of the extrachromosomal element to other microorganisms will be limited by unregulated expression of the lethal genes in the recipient microorganism.
Patent AU-775727-B2 (AU)
Title: Contactless access ticket and method for making same
Inventor: KAYANAKIS GEORGES
IPC: G06K19/07
Filed: 2000-07-07
Granted: 2004-08-12
Abstract: A ticket providing access to a zone with controlled access when it is presented without contact in front of a scanner authorizing access to the zone, the ticket having an Edmonson format and including a paper ticket body covered on both surfaces with a protective coating. The paper ticket body is provided with a through recess where is located an electronic module including an integrated circuit and an antenna. The latter is formed by at least one turn obtained by screen printing with silvery powder in a polymerisable composition before being heat-cured. The ticket provides the advantages of being inexpensive to produce compared to a contactless access card and is highly biodegradable, which is essential for a disposable ticket.
Patent AU-675318-B2 (AU)
Title: Reagents and methods for coupled high temperature reverse transcription and polymerase chain reactions
Inventor: GELFAND DAVID H
IPC: C12Q1/686
Filed: 1994-06-24
Granted: 1997-01-30
Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. The reverse transcription reaction is performed in an appropriate buffer comprising a metal buffer which buffers the divalent cation concentration and which buffer preferably buffers both the pH and the divalent cation concentration. Said divalent cation is preferably Mn<2><+>. In a preferred embodiment, high temperature reverse transcription is coupled to nucleic acid amplification in a one tube, one enzyme procedure using a thermostable DNA polymerase. Methods for eliminating carry over contamination of amplifications due to prior reverse transcription reactions are also provided. Reagents and kits particularly suited for the methods of the present invention are provided. <IMAGE>
Patent AU-654117-B2 (AU)
Title: Aerobic stepping platform
Inventor: IRWIN LYLE RAY
IPC: A63B5/12
Filed: 1990-09-25
Granted: 1994-10-27
Abstract: An adjustable stepping structure (100) for aerobic exercises comprising a platform (117) upon which the participant places his or her feet, the platform being elevated above a support surface by means of one or more support elements (114) which are capable of being detachably stacked upon each other until the platform is maintained at a selected distance above the support surface, depending upon the skill and physical characteristics of the participant.
Patent AU-728428-B2 (AU)
Title: Plant for desalination or purification of sea or brackish water by means of solar energy
Inventor: MARKOPULOS JOHANNES
IPC: B01D3/00
Filed: 1998-03-10
Granted: 2001-01-11
Abstract: PCT No. PCT/AT98/00061 Sec. 371 Date Sep. 10, 1999 Sec. 102(e) Date Sep. 10, 1999 PCT Filed Mar. 10, 1998 PCT Pub. No. WO98/40313 PCT Pub. Date Sep. 17, 1998A facility for the desalination and purification of sea water or brackish water by solar energy provided with a closed cycle including a thermal solar collector and a heat exchanger in which a heat transfer medium is circulating, and a basin for receiving the sea water or brackish water with the heat exchanger being placed in the basin for heating and evaporating water. A cooling surface is disposed above the basing for condensing the evaporated water which is then diverted to water collectors. The solar collector is located above the cooling surface so as to keep it in the shade.
Patent AU-726288-B2 (AU)
Title: Method and apparatus for producing stretch wrap plastic film
Inventor: JOHNSTONE PETER
IPC: B29C55/06
Filed: 1998-05-01
Granted: 2000-11-02
Abstract: The present specification discloses a plastics material film (1) that is stretched beyond its yield point to about 100% to 400% elongation and thereafter only partially relaxed to release part of the elastic deformation component in the film to retain between about 20% and 80% of the elastic deformation in the film (1), the film thereafter being stored in this partially relaxed state whereby, when it is used, the retained elastic deformation capability is useable for the intended purpose of the film, for example, wrapping a load.
Patent AU-638538-B2 (AU)
Title: Display device
IPC: G09F11/02
Filed: 1991-02-01
Granted: 1993-07-01
Abstract: An improved mode of construction is provided for a display device of the kind comprising an array of triangular-section slats 12 rotated in synchronism in 120 DEG steps to present repeatedly to view, in sequence, three compound display surfaces, each carrying a respective poster or the like. In embodiments of the invention, each slat has a respective bearing and driving module 14 with a respective rotary member 22 releasably drivingly engaging the slat 12 and with a respective cam 24, driving the member 22 and driven, in turn by a driving shaft 18, passing through the cams 24 of the modules 14 of all of the slats 12. The modules 14 are received in a stack within a hollow extrusion 10a which forms one side member of a frame of the display device. The opposite side member 10b of the frame receives a stack of bearing members 16 rotatably supporting the opposite ends of the respective slats 12. <IMAGE>